Department of Oncology, Clinical Hospital Centre Split, School of Medicine, University of Split, Split, Croatia.
Department of Pathology, Clinical Hospital Centre Sisters of Mercy, Zagreb, Croatia.
Oncologist. 2021 Jul;26(7):e1156-e1160. doi: 10.1002/onco.13791. Epub 2021 Apr 28.
Our objective was to assess the effects of COVID-19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia.
SUBJECTS, MATERIALS, AND METHODS: We performed a retrospective, population- and registry-based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly diagnosed breast cancer cases.
The average monthly percent change after the initial lockdown measures were introduced was -11.0% (95% confidence interval - 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017-2019.
It seems that national health care system measures for controlling the spread of COVID-19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID-19 control measures were relaxed, and it has not reoccurred during the second COVID-19 wave. Although the COVID-19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020.
It is possible to compensate for the adverse effects of COVID-19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non-negligible extent.
本研究旨在评估新冠防疫措施及其对克罗地亚医疗保健系统功能的后续影响对新诊断乳腺癌病例数量的影响。
对象、材料和方法:我们开展了一项 2020 年的回顾性、基于人群和登记的研究。对照组为 2017 年、2018 年和 2019 年新诊断乳腺癌患者的数量。结局为新诊断乳腺癌病例数量的变化。
在最初的封锁措施实施后,平均每月的百分比变化为-11.0%(95%置信区间为-22.0%至 1.5%),导致克罗地亚 4 月、5 月和 6 月新诊断乳腺癌病例减少 24%,与 2019 年同期相比。然而,2020 年新病例的检出率仅比 2019 年低 1%,或者比 2017-2019 年的线性趋势低 6%。
似乎控制新冠疫情的国家卫生保健系统措施对克罗地亚在第一次封锁期间新诊断乳腺癌病例数量产生了不利影响。由于不太可能期望在同一时间发生流行病学变化,这可能导致以后的诊断、治疗的启动延迟,以及未来的结果较差。然而,这种影响在第一次封锁和放松新冠控制措施后减弱,并且在第二次新冠浪潮中没有再次发生。尽管新冠封锁影响了新诊断乳腺癌的数量,但肿瘤保健系统表现出了弹性,并在 2020 年底弥补了这些影响。
有可能相对迅速地弥补新冠大流行控制措施对乳腺癌诊断的不利影响,尽快做到这一点至关重要。此外,正如本研究在新冠大流行第二次浪潮期间新诊断乳腺癌病例数量的结果所示,这些不利影响在很大程度上是可以预防的。